Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (HK:3320)
:3320
3320 Stock Chart & Stats
HK$4.75
HK$0.05(0.94%)
At close: 4:00 PM EST
HK$4.75
HK$0.05(0.94%)
Day’s Range― - ―
52-Week RangeHK$4.61 - HK$5.94
Previous CloseN/A
Volume6.08M
Average Volume (3M)13.76M
Market Cap
HK$30.72B
Enterprise ValueHK$168.54B
Total Cash (Recent Filing)HK$17.48B
Total Debt (Recent Filing)HK$73.43B
Price to Earnings (P/E)10.1
Beta0.88
Next Earnings
Aug 26, 2025EPS Estimate
0.42Last Dividend Ex-Date
Sep 11, 2025Dividend Yield2.7%
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,282,510,300
10 Day Avg. Volume13,454,154
30 Day Avg. Volume13,759,791
Financial Highlights & Ratios
PEG Ratio-0.57
Price to Book (P/B)0.70
Price to Sales (P/S)0.13
P/FCF Ratio2.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China Resources Pharmaceutical Group Ltd. News
3320 FAQ
What was China Resources Pharmaceutical Group Ltd.’s price range in the past 12 months?
China Resources Pharmaceutical Group Ltd. lowest stock price was HK$4.61 and its highest was HK$5.94 in the past 12 months.
What is China Resources Pharmaceutical Group Ltd.’s market cap?
China Resources Pharmaceutical Group Ltd.’s market cap is HK$30.72B.
When is China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date?
China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date is Aug 26, 2025 which is 66 days ago.
How were China Resources Pharmaceutical Group Ltd.’s earnings last quarter?
China Resources Pharmaceutical Group Ltd. released its earnings results on Mar 26, 2025. The company reported HK$0.122 earnings per share for the quarter, missing the consensus estimate of HK$0.234 by -HK$0.112.
Is China Resources Pharmaceutical Group Ltd. overvalued?
According to Wall Street analysts China Resources Pharmaceutical Group Ltd.’s price is currently Overvalued.
Does China Resources Pharmaceutical Group Ltd. pay dividends?
China Resources Pharmaceutical Group Ltd. pays a Quarterly dividend of HK$0.079 which represents an annual dividend yield of 2.7%. See more information on China Resources Pharmaceutical Group Ltd. dividends here
What is China Resources Pharmaceutical Group Ltd.’s EPS estimate?
China Resources Pharmaceutical Group Ltd.’s EPS estimate is 0.42.
How many shares outstanding does China Resources Pharmaceutical Group Ltd. have?
China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding.
What happened to China Resources Pharmaceutical Group Ltd.’s price movement after its last earnings report?
China Resources Pharmaceutical Group Ltd. reported an EPS of HK$0.122 in its last earnings report, missing expectations of HK$0.234. Following the earnings report the stock price went down -1.519%.
Which hedge fund is a major shareholder of China Resources Pharmaceutical Group Ltd.?
Currently, no hedge funds are holding shares in HK:3320
China Resources Pharmaceutical Group Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
5.90%
Trailing 12-Months
Asset Growth
-0.29%
Trailing 12-Months
Company Description
China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. is a leading pharmaceutical and healthcare company based in China, operating primarily in the pharmaceutical manufacturing, distribution, and retail sectors. The company focuses on a diverse range of products including prescription medications, over-the-counter drugs, health supplements, and medical devices. With an extensive network of subsidiaries and joint ventures, China Resources Pharmaceutical Group plays a pivotal role in the Chinese healthcare market, contributing to the development and accessibility of healthcare solutions across the nation.
Technical Analysis
China Medical System Holdings
―
Guangzhou Baiyunshan Pharmaceutical Holdings Company
―
Livzon Pharmaceutical Group
―
Shanghai Fosun Pharmaceutical (Group) Co
―
Grand Pharmaceutical Group Limited
―
Options Prices
Currently, No data available
---